Real-time enrollment status for this b-cell acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 4:39 AM UTC
| NCT Number | NCT05674175 |
| Recruiting Status | Recruiting |
| Condition | B-cell Acute Lymphoblastic Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 93 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Stephan Grupp MD PhD |
| Last Updated on CT.gov | March 27, 2026 (Mar 27, 2026) |
As of July 20, 2026: Clinical trial NCT05674175 is currently recruiting participants. This phase1 study for b-cell acute lymphoblastic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Stephan Grupp MD PhD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05674175 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05674175 was last updated Mar 27, 2026 (March 27, 2026). HelloStudys verifies this status automatically.